Loading clinical trials...
Loading clinical trials...
The goal of this observational study is to evaluate the long-term clinical effectiveness of EUS-RFA and quality of life in patients with pancreatic or adrenal tumors recieving EUS-RFA. Primary Object...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Herlev Hospital
NCT06441331 · Somatostatin Receptor Positive, NETs, and more
NCT07057622 · NETS Ga68 Lu177
NCT03043508 · Genetic Mutation, MEN1
NCT05605587 · MEN1 Gene Mutation
NCT00001277 · Hyperparathyroidism, Hypercalcemia, and more
Herlev og Gentofte Hospital
Herlev, Capital Region
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions